MedTrace Logo

The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes

NCT04689685 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-09-14

No results posted yet for this study

Summary

The study RADAR aims at developing a wearable based dysglycemia detection and warning system for patients with diabetes mellitus using artificial intelligence.

Conditions

  • Diabetes Mellitus, Insulin-Dependent
  • Diabetes

Interventions

OTHER

Wearing smartwatch and continous glucose sensor

Patients will be wearing a smartwatch and a continuous glucose meter (CGM) over a maximum duration of 3 months in an outpatient setting.

Sponsors & Collaborators

  • ETH Zurich

    collaborator OTHER

  • University of St.Gallen

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Christoph Stettler, Prof. MD · University of Bern

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-19
Primary Completion
2022-03-28
Completion
2022-03-28

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04689685 on ClinicalTrials.gov